Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0000875320-24-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $418.10 | -225 | 7,740 | -3% | -$94.1K | |
| 2024-04-03 | 2024-04-02 | VRTX | Ambrose Kristen | SVP, CAO | S - Sale | $419.00 | -240 | 7,500 | -3% | -$100.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | F | D | 225 | $418.10 | 7,740 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-02 | S | D | 240 | $419.00 | 7,500 | D | — | — |